A Novel Staphylococcus Podophage Encodes a Unique Lysin with Unusual Modular Design
- PMID: 28357414
- PMCID: PMC5362749
- DOI: 10.1128/mSphere.00040-17
A Novel Staphylococcus Podophage Encodes a Unique Lysin with Unusual Modular Design
Abstract
Drug-resistant staphylococci, particularly Staphylococcus aureus and Staphylococcus epidermidis, are leading causes of hospital-acquired infections. Bacteriophages and their peptidoglycan hydrolytic enzymes (lysins) are currently being explored as alternatives to conventional antibiotics; however, only a limited diversity of staphylococcal phages and their lysins has yet been characterized. Here, we describe a novel staphylococcal phage and its lysins. Bacteriophage Andhra is the first reported S. epidermidis phage belonging to the family Podoviridae. Andhra possesses an 18,546-nucleotide genome with 20 open reading frames. BLASTp searches revealed that gene product 10 (gp10) and gp14 harbor putative catalytic domains with predicted peptidase and amidase activities, characteristic functions of phage lysins. We purified these proteins and show that both Andhra_gp10 and Andhra_gp14 inhibit growth and degrade cell walls of diverse staphylococci, with Andhra_gp10 exhibiting more robust activity against the panel of cell wall substrates tested. Site-directed mutagenesis of its predicted catalytic residues abrogated the activity of Andhra_gp10, consistent with the presence of a catalytic CHAP domain on its C terminus. The active site location combined with the absence of an SH3b cell wall binding domain distinguishes Andhra_gp10 from the majority of staphylococcal lysins characterized to date. Importantly, close homologs of Andhra_gp10 are present in related staphylococcal podophages, and we propose that these constitute a new class of phage-encoded lysins. Altogether, our results reveal insights into the biology of a rare family of staphylococcal phages while adding to the arsenal of antimicrobials with potential for therapeutic use. IMPORTANCE The spread of antibiotic resistance among bacterial pathogens is inciting a global public health crisis. Drug-resistant Staphylococcus species, especially S. aureus and S. epidermidis, have emerged in both hospital and community settings, underscoring the urgent need for new strategies to combat staphylococcal infections. Bacterial viruses (phages) and the enzymes that they use to degrade bacterial cell walls (lysins) show promise as alternative antimicrobials; however, only a limited variety of staphylococcal phages and their lysins have yet been identified. Here, we report the discovery and characterization of a novel staphylococcal phage, Andhra. We show that Andhra encodes two lysins (Andhra_gp10 and Andhra_gp14) that inhibit growth and degrade the cell walls of diverse staphylococci, including S. aureus and S. epidermidis strains. Andhra and its unique lysins add to the arsenal of antimicrobials with potential for therapeutic use.
Keywords: Staphylococcus; antimicrobial agents; bacteriophage lysis; bacteriophage therapy; bacteriophages.
Figures


Similar articles
-
Novel recombinant endolysin ointment with broad antimicrobial activity against methicillin-resistant Staphylococcus aureus isolated from wounds and burns.Arch Microbiol. 2023 Mar 4;205(4):104. doi: 10.1007/s00203-023-03434-x. Arch Microbiol. 2023. PMID: 36869962
-
Sequence-Function Relationships in Phage-Encoded Bacterial Cell Wall Lytic Enzymes and Their Implications for Phage-Derived Product Design.J Virol. 2021 Jun 24;95(14):e0032121. doi: 10.1128/JVI.00321-21. Epub 2021 Jun 24. J Virol. 2021. PMID: 33883227 Free PMC article.
-
Biochemical and biophysical characterization of PlyGRCS, a bacteriophage endolysin active against methicillin-resistant Staphylococcus aureus.Appl Microbiol Biotechnol. 2015 Jan;99(2):741-52. doi: 10.1007/s00253-014-5930-1. Epub 2014 Jul 20. Appl Microbiol Biotechnol. 2015. PMID: 25038926
-
Characterization of a Bacteriophage-Derived Murein Peptidase for Elimination of Antibiotic-Resistant Staphylococcus aureus.Curr Protein Pept Sci. 2016;17(2):183-90. doi: 10.2174/1389203716666151102105515. Curr Protein Pept Sci. 2016. PMID: 26521950 Review.
-
Phage-Derived Endolysins Against Resistant Staphylococcus spp.: A Review of Features, Antibacterial Activities, and Recent Applications.Infect Dis Ther. 2025 Jan;14(1):13-57. doi: 10.1007/s40121-024-01069-z. Epub 2024 Nov 16. Infect Dis Ther. 2025. PMID: 39549153 Free PMC article. Review.
Cited by
-
Strategies for Editing Virulent Staphylococcal Phages Using CRISPR-Cas10.ACS Synth Biol. 2017 Dec 15;6(12):2316-2325. doi: 10.1021/acssynbio.7b00240. Epub 2017 Sep 21. ACS Synth Biol. 2017. PMID: 28885820 Free PMC article.
-
Tandem mobilization of anti-phage defenses alongside SCCmec elements in staphylococci.Nat Commun. 2024 Oct 12;15(1):8820. doi: 10.1038/s41467-024-53146-z. Nat Commun. 2024. PMID: 39394251 Free PMC article.
-
Ribitol-Containing Wall Teichoic Acid of Tetragenococcus halophilus Is Targeted by Bacteriophage phiWJ7 as a Binding Receptor.Microbiol Spectr. 2022 Apr 27;10(2):e0033622. doi: 10.1128/spectrum.00336-22. Epub 2022 Mar 21. Microbiol Spectr. 2022. PMID: 35311554 Free PMC article.
-
Phage Genetic Engineering Using CRISPR⁻Cas Systems.Viruses. 2018 Jun 19;10(6):335. doi: 10.3390/v10060335. Viruses. 2018. PMID: 29921752 Free PMC article. Review.
-
Engineered bacteriophages: A panacea against pathogenic and drug resistant bacteria.Heliyon. 2024 Jul 9;10(14):e34333. doi: 10.1016/j.heliyon.2024.e34333. eCollection 2024 Jul 30. Heliyon. 2024. PMID: 39100447 Free PMC article. Review.
References
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources